Healthcare Asia Pharma Awards

It received awards for its child-friendly allergy innovation, reshaping Herpes Zoster care, and Menarini Connect.

A look back at the 2026 Healthcare Asia Awards, Healthcare Asia Pharma Awards, and Healthcare Asia Medtech Awards.

The access programme and advocacy initiative closed affordability gaps for Filipino patients.

The company delivers healthcare services and medicines to underserved families across Philippine communities.

The company strengthens workforce alignment and supply chain reliability to support healthcare in the Philippines.

The initiative marks Atorvastatin’s 25th anniversary by driving nationwide cardiovascular impact.

Community health programme drives trust in generics and sustained health-seeking behaviour.

The recognition highlights a service approach that connects healthcare, education, and ethical practices in Bangladesh.

The company’s programme expands patient access to cancer and chronic kidney disease therapies in Malaysia.

The company’s community healthcare programme expands nationwide access and rapid disaster response.

The Smile Ambassadors programme restores dignity to China’s seniors through community dental care.

The company received national recognition for its culture-building programmes and large-scale community health screenings.

The awards programmes recognise top-notch healthcare providers, pharmaceutical companies, and health tech pioneers for transforming care delivery across Asia.

He explores how healthcare in Asia is evolving and how organisations can manage innovation, regulation, expansion, and future challenges.

He looks into how commercial strategies and technological and operational innovations are driving the healthcare industry today.

She discusses impactful healthcare innovations, partnerships, leadership qualities for scaling across markets, policy engagement, and preparing health systems for demographic shifts.